Human sCD28 Platinum ELISA

Description: The human sCD28 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human sCD28. The human sCD28 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

CD28 is a 44 kDa, disulphide- bonded, homodimeric glycoprotein, which is constitutively expressed on the surface of the majority of T-cells. CD28 is structurally very closely related to another molecule expressed in activated T-cells, CTLA-4. Ligation of CD28 by its counter receptor, B7, expressed on the surface of antigen presenting cells, has been shown to induce signals that, in synergy with those derived from engagement of the T-cell receptor by an antigen bound to a major histocompatibilty complex, enhance proliferation and cytokine production. Manipulation of this interaction can have dramatic effects on the outcome of T-cell activation. Considerable research has been done on the CD28/B7 costimulatory pathway. Blocking thereof results in immunosuppression with implications for the treatment of autoimmune diseases, allergy, organ transplantation and graft versus host disease.
Activating the CD28/B7 pathway could be useful for including the immune system to recognize and eliminate tumors that evade the immune system.

Citations: Wong,C.K.; Ho,A.W.; Tong,P.C.; Yeung,C.Y.; Chan,J.C.; Kong,A.P.; Lam,C.W.. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy. J Clin Immunol 2008;28:36-43. (Link)

Ip,W.K; Wong,C.K.; Leung,T.F.; Lam,C.W.K. Elevation of Plasma Soluble T Cell Costimulatory Molecules CTLA-4, CD28 and CD80 in Children with Allergic Asthma. International Archives of Allergy and Immunology 2005;137:45-52. (Link)

Wong,C.K.; Lit,L.C.W.; Tam,L.S.; Li,E.K.; Lam,C.W.K.. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 2005;44:keh663(Link)

Wong,C.K.; Lun,S.W.M.; Ko,F.W.S.; Ip,W.K.; Hui,D.S.C.; Lam,C.W.K.. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clinical and Experimental Immunology 2005;141:122-129. (Link)

Nolan,Anna; Weiden,Michael; Kelly,Ann; Hoshino,Yoshihiko; Hoshino,Satomi; Mehta,Nehal; Gold,Jeffrey A.. CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis. American Journal of Respiratory and Critical Care Medicine 2008;177:301-308. (Link)

References: Perrin,P.J.; Lovett-Racke,A.; Phillips,S.M.; Racke,M.K.. Differential requirements of naive and memory T cells for CD28 costimulation in autoimmune pathogenesis. Histol.Histopathol. 1999;14:1269-1276. (Link)

Guinan,E.C.; Gribben,J.G.; Boussiotis,V.A.; Freeman,G.J.; Nadler,L.M.. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994;84:3261-3282. (Link)

Sharpe,A.H.; Freeman,G.J.. The B7-CD28 superfamily 109. Nat.Rev.Immunol. 2002;2:116-126. (Link)

Bour-Jordan,H.; Blueston,J.A.. CD28 function: a balance of costimulatory and regulatory signals. J.Clin.Immunol. 2002;22:1-7. (Link)

Daikh,D.; Wofsy,D.; Imboden,J.B.. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J.Leukoc.Biol. 1997;62:156-162. (Link)

Salmaso,C.; Olive,D.; Pesce,G.; Bagnasco,M.. Costimulatory molecules and autoimmune thyroid diseases. Autoimmunity 2002;35:159-167. (Link)

Edmead,C.E.; Lamb,J.R.; Hoyne,G.F.. The T cell surface protein, CD28. Int.J.Biochem.Cell Biol. 1997;29:1053-1057. (Link)

June,C.H.; Ledbetter,J.A.; Linsley,P.S.; Thompson,C.B.. Role of the CD28 receptor in T-cell activation. Immunol.Today 1990;11:211-216. (Link)

Salomon,B.; Bluestone,J.A.. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu.Rev.Immunol. 2001;19:225-252. (Link)

Balzano,C.; Buonavista,N.; Rouvier,E.; Golstein,P.. CTLA-4 and CD28: similar proteins, neighbouring genes. Int.J.Cancer Suppl 1992;7:28-32. (Link)

Anderson,D.E.; Sharpe,A.H.; Hafler,D.A.. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system 1. Curr.Opin.Immunol. 1999;11:677-683. (Link)

Bocko,D.; Kosmaczewska,A.; Ciszak,L.; Teodorowska,R.; Frydecka,I.. CD28 costimulatory molecule--expression, structure and function. Arch.Immunol.Ther.Exp.(Warsz.) 2002;50:169-177. (Link)

Alegre,M.L.; Frauwirth,K.A.; Thompson,C.B.. T-cell regulation by CD28 and CTLA-4. Nat.Rev.Immunol. 2001;1:220-228. (Link)

Herold,K.G.; Lenschow,D.J.; Bluestone,J.A.. CD28/B7 regulation of autoimmune diabetes. Immunol.Res. 1997;16:71-84. (Link)

Linsley,P.S.; Ledbetter,J.A.. The role of the CD28 receptor during T cell responses to antigen. Annu.Rev.Immunol. 1993;11:191-212. (Link)

Greenfield,E.A.; Nguyen,K.A.; Kuchroo,V.K.. CD28/B7 costimulation: a review. Crit Rev.Immunol. 1998;18:389-418. (Link)

Harlan,D.M.; Abe,R.; Lee,K.P.; June,C.H.. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin.Immunol.Immunopathol. 1995;75:99-111. (Link)

Karandikar,N.J.; Vanderlugt,C.L.; Bluestone,J.A.; Miller,S.D.. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. J.Neuroimmunol. 1998;89:10-18. (Link)